Amgen Absorbs Horizon, Pitches Plans For New Rare Disease Growth Engine

Full-Year 2023 Guidance Raised By At Least $1bn

 
• By Mandy Jackson
Mountain road. Landscape with green field, sunny sky with clouds and beautiful asphalt road in the morning. Scenic background.
Horizon brings Amgen a multi-drug rare disease portfolio • Source: Shutterstock

More from Earnings

More from Business